Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Widespread pain puts patients at a 29% higher risk of stroke

For patients over the age of 65, the stroke risk climbs all the way to 54%. Researchers emphasized how important it is to begin treatment as early as possible. 

Rivaroxaban limits adverse limb and cardiovascular events in surgically treated PAD patients

Rivaroxaban was associated with more bleeding than a placebo, researchers observed, but the overall incidence of such events was still low.

Thumbnail

Small amounts of exercise can help stroke survivors reduce risk of death by 54%

Physical activities such as walking and gardening are especially important after a stroke for younger patients, researchers found.

Thumbnail

Stroke care during the pandemic's first wave included younger patients, lower survival rates

More patients also required endovascular thrombectomy treatment than usual.

Thumbnail

Risk of ischemic stroke much smaller with TAVR than SAVR when patient has a history of stroke

The new analysis included more than 92,000 TAVR patients and more than 68,000 SAVR patients.

Avoiding hospitals due to COVID-19 put heart attack, stroke patients on Medicare at risk

“Hospitalizations for acute myocardial infarction and stroke declined nationwide among adults during the early COVID-19 period, suggesting some patients did not receive timely care for these emergencies,” researchers said.  

On-site stroke therapy tied to better clinical outcomes

A new analysis reveals that bringing stroke treatment to the patient yields better functional outcomes.

Thumbnail

FDA grants breakthrough device designation to new chronic venous insufficiency device

A new clinical study is scheduled to begin in the near future.